Cardiff Lexington Corp

CDIXSEC EDGAR

Services-Offices & Clinics of Doctors of Medicine(FL)CIK: 811222

Concept	FY2025	FY2024	FY2023	FY2022	FY2018
Cost of Goods and Services Sold	—	—	—	—	$1.4M
Gross Profit	$4.4M	$8.3M	$6.6M	$6.1M	$193.9K
Selling, General and Administrative Expense	$4.1M	$3.1M	$2.7M	$4.4M	$2.1M
Operating Expenses	$4.6M	$3.1M	$2.7M	$4.4M	$3.2M
Operating Income (Loss)	-$193.5K	$5.2M	$3.9M	$1.7M	-$3.0M
Interest Expense	—	—	—	—	$111.7K
Nonoperating Income (Expense)	-$3.0M	-$2.1M	-$7.2M	-$2.0M	-$659.5K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$3.2M	$3.1M	-$3.3M	-$303.6K	—
Income Tax Expense (Benefit)	$0.00	—	—	—	—
Net Income (Loss) Attributable to Parent	-$3.3M	$3.0M	-$5.4M	$666.3K	-$3.7M
Earnings Per Share, Basic	—	—	—	-$0.01	—
Earnings Per Share, Diluted	—	—	—	-$0.01	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2018
Assets	$23.9M	$20.7M	$13.3M	$15.3M	$1.3M
Assets, Current	$17.2M	$14.2M	$6.8M	$6.6M	$190.6K
Cash and Cash Equivalents, at Carrying Value	—	—	—	—	$62.9K
Accounts Receivable, after Allowance for Credit Loss, Current	$13.3M	$6.6M	$6.6M	$6.0M	$63.1K
Inventory, Net	—	—	—	—	$46.9K
Liabilities	$16.3M	$14.1M	$10.2M	$11.4M	$4.7M
Liabilities, Current	$15.9M	$13.9M	$10.0M	$11.2M	$4.7M

Concept	FY2025	FY2024	FY2023	FY2022	FY2018
Net Cash Provided by (Used in) Operating Activities	—	—	-$1.2M	—	-$614.9K
Net Cash Provided by (Used in) Investing Activities	—	—	—	-$2.3M	-$12.8K
Net Cash Provided by (Used in) Financing Activities	$3.0M	$2.4M	$788.8K	$3.7M	$633.7K
Payments to Acquire Property, Plant, and Equipment	—	—	—	$3.4K	$0.00
Payments of Dividends	$100.0K	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)